Neurometrix Inc
(NURO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,773 | -2,716 | -1,312 | 2,051 | 24 |
| Depreciation Amortization | 124 | 98 | 108 | 32 | 170 |
| Accounts receivable | 735 | 559 | 356 | 111 | 1,320 |
| Accounts payable and accrued liabilities | -572 | -660 | -287 | -740 | 572 |
| Other Working Capital | -3,208 | -3,722 | -3,278 | -2,406 | 2,222 |
| Other Operating Activity | 3,073 | 2,881 | 2,591 | 1,374 | -1,446 |
| Operating Cash Flow | $-3,621 | $-3,560 | $-1,822 | $420 | $2,862 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -48 | -41 | -8 | N/A | -144 |
| Investing Cash Flow | $-48 | $-41 | $-8 | $0 | $-144 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15 | 8 | 8 | 0 | 19 |
| Financing Cash Flow | $15 | $8 | $8 | $0 | $19 |
| Beginning Cash Position | 6,780 | 6,780 | 6,780 | 6,780 | 4,044 |
| End Cash Position | 3,126 | 3,187 | 4,958 | 7,201 | 6,780 |
| Net Cash Flow | $-3,654 | $-3,594 | $-1,822 | $420 | $2,737 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,621 | -3,560 | -1,822 | 420 | 2,862 |
| Capital Expenditure | -48 | -41 | -8 | N/A | -144 |
| Free Cash Flow | -3,669 | -3,601 | -1,830 | 420 | 2,718 |